Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist.

导出 LinkOut

翻译打印收藏纠错

作者： Paul,Hofman ^[1] ; Iordanis,Ourailidis ^[2] ; Eva,Romanovsky ^[2] ; Marius,Ilié ^[3] ; Jan,Budczies ^[2] ; Albrecht,Stenzinger ^[2]

作者单位： Laboratory of Clinical and Experimental Pathology, IHU RespirERA, FHU OncoAge, Biobank BB-0033-00025, IRCAN, Côte d'Azur University, 30 avenue de la voie romaine 06002 Nice cedex 01, France. Electronic address: hofman.p@chu-nice.fr. ^[1] Institute of Pathology Heidelberg, University Hospital Heidelberg, In Neuenheimer Feld 224 69120 Heidelberg, Germany. ^[2] Laboratory of Clinical and Experimental Pathology, IHU RespirERA, FHU OncoAge, Biobank BB-0033-00025, IRCAN, Côte d'Azur University, 30 avenue de la voie romaine 06002 Nice cedex 01, France. ^[3]

关键词 Artificial intelligence Biomarkers Diagnosis Lung cancer Molecular biology Pathology

主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);人工智能(Artificial Intelligence);预后(Prognosis);算法(Algorithms)

DOI 10.1016/j.lungcan.2025.108110

PMID 39879785

发布时间 2025-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交